Tech[COVID-19 Update] Early Results of Sinovac's Coronavirus Vaccine Show 90% of Trial Volunteers Developed Antibodies The Beijing-based Sinovac Biotech Ltd. claims to have positive early data from their human trials of its COVID-19 vaccine with more than 90% of trial participants developing antibodies after two weeks.by CJ Robles
HealthCoronavirus: U.S. Army to Begin Vaccine Human Trials in Two Months; Risk Factors for Severe COVID-19 Identifiedby Nhx T.
HealthCOVID-19: Pharma Company AstraZeneca Will Start Production of Potential Coronavirus Vaccineby Nhx Tingson
HealthOxford's COVID-19 Vaccine Won't be Available in the U.S. Immediately; Mother's Day Event Invited Patient, Now Over 180 Maybe Infectedby Jamie P.
HealthCOVID-19 Vaccine Might be Released Unapproved; Chinese Drugmaker Will be Testing Top Vaccine Candidate Globallyby Nhx Tingson
HealthPromising COVID-19 Vaccine Has Protected Monkeys From Coronavirus According to Studyby Nhx Tingson
HealthCoronavirus Vaccine: MMR Vaccine Eyed as Protection Against COVID-19 Complicationsby Nhx Tingson
HealthNew Coronavirus Mutation Strain Found Which Could Potentially Hinder COVID-19 Vaccine Developmentby Nhx Tingson
HealthPotential Coronavirus Cure can 'Block and Stop' Virus as Scientist Makes Major Breakthrough in Searching COVID-19 Vaccineby Nhx Tingson
HealthCoronavirus Vaccine Has Possibly Been Hidden Around for 100 Years; We Just Don't Know it Yetby Jamie P.